Policy snapshot: Health care
INSIGHT ARTICLE |
Authored by RSM US LLP
Joe Biden is the projected winner of the presidential election, while control of the Senate will be won only by a slim margin following runoff elections for Georgia’s two seats in January. What does a divided government mean for the middle market? RSM is looking at the policy implications and key issues for various industries. This is one in our series of industry-focused outlooks for a Biden administration.
According to Joe Biden’s plan:
Biden will want to strengthen and expand the Affordable Care Act; however, he could face Senate opposition or risk expansion, through executive orders, that could be undone by a later administration. While we won’t have the Supreme Court’s opinion for months, the candor of the oral arguments suggest the law will largely survive its latest legal challenge. The outlook for Biden’s cornerstone public option, which would allow Americans to buy into a Medicare-like program as early as age 60, also seems unlikely to pass a divided Congress. The Biden administration and congressional Democrat caucuses are also likely to continue the bipartisan push to address so-called surprise medical billing practices and prescription drug costs.
What a closely divided Senate means for health care:
The Medicare public option is not likely to pass a divided Congress; we are more likely to see executive orders and perhaps, at minimum, proposed legislation on surprise billing and drug pricing. These potentially quicker wins for Biden and the Democrats may have significant repercussions throughout the health care ecosystem. Additionally, we expect increased federal antitrust oversight of health care mergers and acquisitions. Vice President-elect Harris’s history as Attorney General of California suggests she may make a point to scrutinize such deals, which some research suggests leads to higher prices for patients. We may also see expanded scrutiny of private equity’s investment in health care providers. President Trump and his administration have been pushing a value-based care model in Medicare since they took office. We are unsure this will be an emphasis for Biden’s administration; however, value-based care is one area with general bipartisan support.
What room for growth or evolution exists in health care?
Drug and procedure costs, price and quality transparency and the future of telehealth regulations and reimbursement are issues for the incoming administration to address. Both Democrats and Republicans have largely agreed that health care in America costs too much. The Republican strategy has been to provide patients with the information they need to make their own health care decisions through initiatives like pricing transparency and short-term health coverage. We expect the Biden administration and congressional Democrats to push for lower costs; however, the strategy will center less on patient choice and more on leveraging the power of the federal government to negotiate or mandate change.
Questions that frame the path forward:
- What could significant shifts in a payer mix, from commercially insured to Medicare, mean for different groups of providers?
- What role will investors have in health care provider subsectors? Will they continue to provide capital in this space?
- What is the future of virtual health care in the industry and how will policy continue to shape it?
- As health care moves to virtual environments and integrates with wearable and other alternative data, have providers mitigated risks and addressed burgeoning cybersecurity challenges?
- How will the pandemic continue to affect the industry and what will be the additional long-term effects on the workforce, operations, patient care and more?
Call us at (325) 677-6251 or fill out the form below and we'll contact you to discuss your specific situation.
This article was written by Jessika Garis, Lori Kalic, Rick Kes, Matt Wolf and originally appeared on 2020-11-19.
2020 RSM US LLP. All rights reserved.
RSM US Alliance provides its members with access to resources of RSM US LLP. RSM US Alliance member firms are separate and independent businesses and legal entities that are responsible for their own acts and omissions, and each is separate and independent from RSM US LLP. RSM US LLP is the U.S. member firm of RSM International, a global network of independent audit, tax, and consulting firms. Members of RSM US Alliance have access to RSM International resources through RSM US LLP but are not member firms of RSM International. Visit rsmus.com/about us for more information regarding RSM US LLP and RSM International. The RSM logo is used under license by RSM US LLP. RSM US Alliance products and services are proprietary to RSM US LLP.
Condley and Company, LLP is a proud member of the RSM US Alliance, a premier affiliation of independent accounting and consulting firms in the United States. RSM US Alliance provides our firm with access to resources of RSM US LLP, the leading provider of audit, tax and consulting services focused on the middle market. RSM US LLP is a licensed CPA firm and the U.S. member of RSM International, a global network of independent audit, tax and consulting firms with more than 43,000 people in over 120 countries.
Our membership in RSM US Alliance has elevated our capabilities in the marketplace, helping to differentiate our firm from the competition while allowing us to maintain our independence and entrepreneurial culture. We have access to a valuable peer network of like-sized firms as well as a broad range of tools, expertise and technical resources.
For more information on how Condley and Company can assist you, please call (325) 677-6251.